Advanced in VEXAS Syndrome

Dr. Nancy J. Walker

Rheumatology
Arthritis And Osteoporosis Center, Inc.
2760 Century Blvd, Suite 3, 
Wyomissing, PA 
Advanced in VEXAS Syndrome
Arthritis And Osteoporosis Center, Inc.
2760 Century Blvd, Suite 3, 
Wyomissing, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nancy Walker is a Rheumatologist in Wyomissing, Pennsylvania. Dr. Walker is rated as an Advanced provider by MediFind in the treatment of VEXAS Syndrome. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Rheumatoid Arthritis (RA), and Rhizomelic Pseudopolyarthritis.

Her clinical research consists of participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in CO
Hospital Affiliations
Wellspan Good Samaritan Hospital
Penn State Health St. Joseph
Wellspan Ephrata Community Hospital
Reading Hospital
Surgical Institute Of Reading
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

ARTHRITIS AND OSTEOPOROSIS CENTER, INC.
2760 Century Blvd, Suite 3, Wyomissing, PA 19610

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 2 Less Clinical Trials
Similar Doctors
Advanced in VEXAS Syndrome
Dr. Eleni Tiniakou
Rheumatology
Advanced in VEXAS Syndrome
Dr. Eleni Tiniakou
Rheumatology

Blue Hen Physical Therapy Inc

425 New London Rd, 
Newark, DE 
 (47.3 miles away)
302-453-1588
Languages Spoken:
English, German, Greek
See accepted insurances
Accepting New Patients

Eleni Tiniakou is a Rheumatologist in Newark, Delaware. Dr. Tiniakou is rated as a Distinguished provider by MediFind in the treatment of VEXAS Syndrome. Her top areas of expertise are Dermatomyositis, Myositis, Polymyositis, and Necrotizing Myopathy (NM). Dr. Tiniakou is currently accepting new patients.

Advanced in VEXAS Syndrome
Dr. Michael George
Rheumatology
Advanced in VEXAS Syndrome
Dr. Michael George
Rheumatology

Penn Rheumatology Perelman

3400 Civic Center Boulevard, South Pavilion, 1st Floor, 
Philadelphia, PA 
 (50.8 miles away)
215-662-2454
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael George is a Rheumatologist in Philadelphia, Pennsylvania. Dr. George has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of VEXAS Syndrome. His top areas of expertise are Dermatomyositis, Polymyositis, Interstitial Lung Disease, and VEXAS Syndrome. Dr. George is currently accepting new patients.

Advanced in VEXAS Syndrome
Dr. Charles F. Henderson
Rheumatology
Advanced in VEXAS Syndrome
Dr. Charles F. Henderson
Rheumatology

Lancaster General Medical Group

2150 Harrisburg Pike, Suite 200a, 
Lancaster, PA 
 (28.1 miles away)
717-544-3059
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Charles Henderson is a Rheumatologist in Lancaster, Pennsylvania. Dr. Henderson is rated as a Distinguished provider by MediFind in the treatment of VEXAS Syndrome. His top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Calcium Pyrophosphate Arthritis, and Rheumatoid Arthritis (RA).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Walker's expertise for a condition
ConditionClose
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile